- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.06. | Neuralink raises $650m to widen use of brain implants | ||
| 04.06. | Ascletis says oral acne drug shows "exceptional efficacy" | ||
| 04.06. | Hims & Hers buys Zava to form European beachhead | ||
| 04.06. | MSD rumoured to be eyeing $3bn+ MoonLake takeover | ||
| 04.06. | ASCO 25: Sanofi hopes on-body delivery will boost Sarclisa | ||
| 04.06. | ASCO 25: J&J combo pill may see wider use in prostate cancer | ||
| 03.06. | Amid staff cuts, FDA looks to AI to 'optimise' reviews | ||
| 03.06. | ASCO 25: Enhertu bids for earlier use in HER2+ breast cancer | ||
| 02.06. | Consolidation in psychedelics as atai pairs with Beckley | ||
| 02.06. | BioNTech flips its cancer bispecific to BMS for a big profit | ||
| 02.06. | ASCO 25: AZ pitches upfront oral SERD use in breast cancer | ||
| 02.06. | 23andMe founder isn't giving up her bid to regain control | ||
| 02.06. | Sanofi draws up $9.1bn plan to buy Blueprint Medicines | ||
| 30.05. | Summit shrugs off survival miss with its VEGF bispecific | ||
| 30.05. | Astellas adds to claudin clout with $1.3bn+ Evopoint deal | ||
| 30.05. | Roche builds case for MS drug with two-year efficacy data | ||
| 30.05. | Axe falls on Stealth Bio staff after FDA rejects lead drug | ||
| 30.05. | GRIN raises $140m for epilepsy drug, and other financings | ||
| 29.05. | MSD and Daiichi Sankyo pull HER3-DXd's FDA filing | ||
| 29.05. | Old COVID tweet lands Pfizer in new trouble with PMCPA | ||
| 29.05. | Moderna's $760m-plus flu vaccine contracts are nixed by HHS | ||
| 29.05. | Data sets up filing of new GSK antibiotic this year | ||
| 29.05. | Eisai says patent win blocks Lenvima generic to 2036 | ||
| 28.05. | InflaRx stock halves after it drops lead drug | ||
| 28.05. | FDA fast-tracks Teva's coeliac disease treatment |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .